Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA etoposide GDSC1000 pan-cancer AAC -0.069 0.05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA Topotecan CCLE pan-cancer AAC -0.082 0.06
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.06 0.06
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.068 0.06
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.069 0.06
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.063 0.06
mRNA PIK-93 CTRPv2 pan-cancer AAC 0.065 0.06
mRNA AMG-706 GDSC1000 pan-cancer AAC -0.066 0.06
mRNA prochlorperazine CTRPv2 pan-cancer AAC 0.068 0.06
Download CSV